Back to search
FDAFDA · Food and drugs·Recall number Z-0694-2025

Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400

Published January 1, 2025 · Recall initiated: November 8, 2024

Summary

FDA records medical device Class II recall Z-0694-2025, published January 1, 2025 and initiated November 8, 2024. Recalling firm: Hologic, Inc.; Status: Ongoing; Reported quantity: 3; Lot: UDI-DI: 15420045515352 Kit lot 892307, Expiration: May 15, 2025. Cartridge Lot 890494. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

SARS-CoV-2/Flu A/B/RSV Assay Kit may erroneously produce SARS-CoV-2 false positive results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hologic, Inc.
Distributor
US: AK
Lot
UDI-DI: 15420045515352 Kit lot 892307, Expiration: May 15, 2025. Cartridge Lot 890494
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400 recalled?

Yes. FDA published recall Z-0694-2025 on January 1, 2025. Reported hazard: SARS-CoV-2/Flu A/B/RSV Assay Kit may erroneously produce SARS-CoV-2 false positive results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter